🇺🇸 FDA
Patent

US 12138243

Antiviral use of FABP4 modulating compounds

granted A61KA61K31/404A61K45/06

Quick answer

US patent 12138243 (Antiviral use of FABP4 modulating compounds) held by CRESCENTA BIOSCIENCES expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRESCENTA BIOSCIENCES
Grant date
Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
50
CPC classes
A61K, A61K31/404, A61K45/06, A61P, A61P31/12